We are live on ! Find out more
ANAC

ANACOR PHARMACEUTICALS INC COM
ANAC

Delisted

ANAC was delisted on the 23rd of June, 2016.

Back to rankings

116 hedge funds and large institutions have $940M invested in ANACOR PHARMACEUTICALS INC COM in 2014 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 39 increasing their positions, 33 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

153% more call options, than puts

Call options by funds: $6.85M | Put options by funds: $2.71M

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

58% more capital invested

Capital invested by funds: $596M → $940M (+$344M)

53% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 17

18% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 33

8% more funds holding

Funds holding: 107 → 116 (+9)

Holders
116
Holders Change
+9
Holders Change %
+8.41%
% of All Funds
3.37%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.15%
New
26
Increased
39
Reduced
33
Closed
17
Calls
$6.85M
Puts
$2.71M
Net Calls
+$4.14M
Net Calls Change
+$3.17M

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$31.6M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$30.5M
3
BBA
Baker Bros. Advisors
New York
+$19.4M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$16.4M
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$12.2M

Top Sellers

Rank Fund Capital Flow
1
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$29.4M
2
BC
Broadfin Capital
New York
-$13.5M
3
QF
QVT Financial
New York
-$10.3M
4
PA
Perceptive Advisors
New York
-$9.38M
5
KCM
Kingdon Capital Management
New York
-$8.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
Macquarie Group
51
Macquarie Group
Australia
$1.56M +$1.3M +63,961 New
Wells Fargo
52
Wells Fargo
California
$1.53M +$210K +10,338 +20%
California State Teachers Retirement System (CalSTRS)
53
California State Teachers Retirement System (CalSTRS)
California
$1.49M +$13.1K +645 +1%
ARTA
54
A.R.T. Advisors
New York
$1.29M +$398K +19,591 +59%
EAM
55
EverPoint Asset Management
Connecticut
$1.22M +$1.02M +50,000 New
EI
56
EAM Investors
California
$1.22M – – –
Morgan Stanley
57
Morgan Stanley
New York
$1.17M -$1.17M -57,558 -55%
AQR Capital Management
58
AQR Capital Management
Connecticut
$1.14M -$417K -20,500 -31%
TA
59
Teachers Advisors
New York
$1.13M – – –
D.E. Shaw & Co
60
D.E. Shaw & Co
New York
$1.06M +$469K +23,078 +114%
AllianceBernstein
61
AllianceBernstein
Tennessee
$1.04M +$20.3K +1,000 +2%
RFC
62
Russell Frank Company
Washington
$990K – – –
NFA
63
Nationwide Fund Advisors
Ohio
$979K +$300K +14,761 +58%
Invesco
64
Invesco
Georgia
$964K +$800K +39,380 New
California Public Employees Retirement System
65
California Public Employees Retirement System
California
$891K – – –
RhumbLine Advisers
66
RhumbLine Advisers
Massachusetts
$887K -$14.2K -700 -2%
Swiss National Bank
67
Swiss National Bank
Switzerland
$869K – – –
TI
68
Turner Investments
Pennsylvania
$869K +$721K +35,500 New
Susquehanna International Group
69
Susquehanna International Group
Pennsylvania
$859K +$442K +21,740 +163%
ProShare Advisors
70
ProShare Advisors
Maryland
$847K -$137K -6,749 -16%
AL
71
Airain Ltd
Guernsey
$791K +$657K +32,344 New
State Board of Administration of Florida Retirement System
72
State Board of Administration of Florida Retirement System
Florida
$659K – – –
RNS
73
Robert N. Shapiro
$654K +$266K +13,101 +96%
MLICM
74
Metropolitan Life Insurance Company (MetLife)
New York
$612K +$41.1K +2,021 +9%
DekaBank Deutsche Girozentrale
75
DekaBank Deutsche Girozentrale
Germany
$602K +$12.2K +600 +3%
1 2
3
4 5

ANAC Hedge Fund Activity: Q3 2014 in Review

116 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q3 2014, worth a combined $940M — up 58% from $596M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ANAC positions and 17 closed out — a net gain of 9 holders — while 39 added to existing stakes and 33 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $31.6M. The largest seller was Westfield Capital Management, exiting entirely with an estimated $29.4M sold.

  • 116 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q3 2014, up from 107 in Q2 2014.
  • Funds reported $940M of ANACOR PHARMACEUTICALS INC COM stock for Q3 2014, up 58% quarter-over-quarter.
  • 26 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q3 2014 and 17 closed out, a net change of +9 holders.
  • The largest ANACOR PHARMACEUTICALS INC COM buyer in Q3 2014 was Point72 Asset Management, an estimated $31.6M added.
  • The largest ANACOR PHARMACEUTICALS INC COM seller in Q3 2014 was Westfield Capital Management, an estimated $29.4M sold.

Based on aggregated 13F filings for Q3 2014.